Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06009848
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-08-19
Brief Title:
Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer
Sponsor:
Tianjin Medical University Second Hospital
Organization:
Tianjin Medical University Second Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-19
First Submit QC Date:
August 23 2023
Study First Post Date:
2023-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-23
Last Update Post Date:
2023-08-24
Last Update Post Date Type:
ACTUAL